Canada markets open in 9 hours 18 minutes

Viking Therapeutics, Inc. (VKTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
76.97+1.21 (+1.60%)
At close: 04:00PM EDT
77.00 +0.03 (+0.04%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.49B
Enterprise Value 7.53B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)9.09
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -65.97

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 3231.41%
S&P500 52-Week Change 322.38%
52 Week High 399.41
52 Week Low 38.28
50-Day Moving Average 371.47
200-Day Moving Average 329.93

Share Statistics

Avg Vol (3 month) 36.62M
Avg Vol (10 day) 32.91M
Shares Outstanding 5110.27M
Implied Shares Outstanding 6110.22M
Float 8104.31M
% Held by Insiders 16.03%
% Held by Institutions 172.93%
Shares Short (Apr 15, 2024) 411.15M
Short Ratio (Apr 15, 2024) 42.53
Short % of Float (Apr 15, 2024) 413.63%
Short % of Shares Outstanding (Apr 15, 2024) 410.11%
Shares Short (prior month Mar 15, 2024) 411.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-12.78%
Return on Equity (ttm)-17.55%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-93.72M
Diluted EPS (ttm)-0.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)962.98M
Total Cash Per Share (mrq)8.73
Total Debt (mrq)1.18M
Total Debt/Equity (mrq)0.13%
Current Ratio (mrq)29.49
Book Value Per Share (mrq)8.47

Cash Flow Statement

Operating Cash Flow (ttm)-54.87M
Levered Free Cash Flow (ttm)-22.44M